It is noteworthy that in vitro experiments with LOXs inhibitors showed a prominent role of LOXL-2 versus LOX in tumor growth, collagen cross-linking, angiogenesis, and fibroblast activation [82]. The gene discussed is LOX; the disease is neoplasm.